Change search criteria ↓

Search results

623 projects found matching your search criteria:

  1. 1. Dioscuri Center for Structural Dynamics of Receptors

    Principal investigator: Przemysław Nogły

    Uniwersytet Jagielloński

    Call: DIOSCURI 4, Panel: NZ1

  2. 2. New selective antagonists of ionotropic glutamate non-NMDA receptors

    Principal investigator: dr Ewa Monika Szymańska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 8, Panel: NZ7

  3. 3. New receptors for C-reactive protein recognition - generation, characterization and application towards fast differentia…

    Principal investigator: dr Katarzyna Szot-Karpińska

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

    Call: SONATA 13, Panel: ST5

  4. 4. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan…

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii PAN

    Call: OPUS 19, Panel: NZ7

  5. 5. Role of peroxisome proliferator-activated receptors (PPARs) and free fatty acid receptors (FFARs) in androgen-dependent …

    Principal investigator: Julia Anna Wajda

    Uniwersytet Jagielloński, Wydział Biologii

    Call: PRELUDIUM 21, Panel: NZ3

  6. 6. Molecular receptors as a tool for studies of interactions agonist/antagonist of H1 - H4 receptors

    Principal investigator: Małgorzata Ewa Walczak

    Politechnika Łódzka, Wydział Chemiczny

    Call: PRELUDIUM 11, Panel: ST5

  7. 7. The influence of muscarinic acetylcholine receptors (M1, M4 and M5) and serotonergic 5-HT1A receptor modulation on cogni…

    Principal investigator: dr Paulina Agnieszka Cieślik

    Instytut Farmakologii PAN

    Call: PRELUDIUM 16, Panel: NZ7

  8. 8. A clinicopathological analysis of breast cancer with single hormone receptor positive phenotype including a quantitative…

    Principal investigator: dr Elżbieta Maria Senkus-Konefka

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 13, Panel: NZ5

  9. 9. Crosstalk between fibroblast growth factor receptors signaling and regulation of vitamin D receptor in leukemogenesis.

    Principal investigator: prof. Ewa Teresa Marcinkowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 12, Panel: NZ5

  10. 10. Crosstalk between vitamin D receptor (VDR) and retinoic acid receptors (RARs) in hematopoiesis.

    Principal investigator: prof. Ewa Teresa Marcinkowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 9, Panel: NZ4

  11. 11. Neurotoxic effects of benzophenone-3 : the role of estrogen receptors and retinoid X receptor alpha.

    Principal investigator: Agnieszka Wnuk

    Instytut Farmakologii PAN

    Call: PRELUDIUM 7, Panel: NZ4

  12. 12. Structure-activity relationship of bifunctional peptides, agonists of opioid receptors and antagonists of neurokinin rec…

    Principal investigator: Jolanta Dyniewicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 2, Panel: ST5

  13. 13. Effect of gene polymorphisms of vitamin D receptor (VDR) and the calcium receptor (CASR) in the AD.

    Principal investigator: dr Łukasz Łaczmański

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski Kształcenia Podyplomowego

    Call: OPUS 1, Panel: NZ7

  14. 14. Positioning the aryl hydrocarbon receptor (AhR) as a new target for pharmacotherapy of sporadic Alzheimer disease: verif…

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

    Call: OPUS 28, Panel: NZ7

  15. 15. Potential neuroprotective properties of modulators of sphingosine-1-phosphate (S1P) receptors (fingolimod and siponimod)…

    Principal investigator: Iga Wieczorek

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 20, Panel: NZ5

  16. 16. Relatioship between activation of FGFR-mediated signalling and loss of progesterone receptor in estrogen receptor-positi…

    Principal investigator: prof. Radzisław Kordek

    Uniwersytet Medyczny w Łodzi, Katedra Onkologii, Zakład Patologii

    Call: OPUS 9, Panel: NZ4

  17. 17. Novel type modulators of purinergic receptors - Synthesis and study of receptor-ligand interaction

    Principal investigator: prof. Zbigniew Jan Leśnikowski

    Instytut Biologii Medycznej PAN

    Call: OPUS 7, Panel: NZ1

  18. 18. Involvement of estrogen receptors, aromatic hydrocarbons receptors and PPAR gamma receptors in the mechanism of endocrin…

    Principal investigator: dr hab. Anna Katarzyna Wójtowicz

    Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie, Wydział Hodowli i Biologii Zwierząt

    Call: OPUS 4, Panel: NZ4

  19. 19. Dual Se-containing 5-HT1A and 5-HT7 biased agonists activating sigma-1 receptor as a hope of finding fast-acting antidep…

    Principal investigator: prof. Karolina Anna Pytka

    Uniwersytet Jagielloński

    Call: OPUS 27, Panel: NZ7

  20. 20. Połączone działanie agonistów receptorów adenozynowych i antagonistów receptora P2Y12 zwiększa hamowanie funkcji płytek …

    Principal investigator: Nina Małgorzata Wolska

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

    Call: ETIUDA 7, Panel: NZ3

  21. 21. Mechanisms underlying insulin resistance in patients with pulmonary arterial hypertension. The role of peroxisome prolif…

    Principal investigator: dr hab. Grzegorz Kopeć

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum

    Call: SONATA BIS 7, Panel: NZ5

  22. 22. Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas…

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ7

  23. 23. The role of nitric oxide-dependent pathways in the procognitive effects of muscarinic and metabotropic glutamate recepto…

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

    Call: OPUS 17, Panel: NZ7

  24. 24. Studies on apoptosis and oxidative damage to biological molecules in tissue-specific and non-specific growth hormone rec…

    Principal investigator: dr hab. Adam Gesing

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski z Oddziałem Stomatologicznym

    Call: HARMONIA 2, Panel: NZ4

  25. 25. Role of Pregnane-X-receptor (PXR) in the pathogenesis of primary sclerosing cholangitis (PSC)

    Principal investigator: prof. Piotr Milkiewicz

    Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarski z Oddziałem Nauczania w Języku Angielskim

    Call: OPUS 1, Panel: NZ5

  26. 26. Self-learning systems in the design of compounds modulating GPCR receptors activation.

    Principal investigator: dr hab. Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

    Call: OPUS 20, Panel: NZ2

  27. 27. Search for new "drug-like" molecules designed as adenosine receptors ligands

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: HARMONIA 2, Panel: NZ4

  28. 28. Adopted orphan nuclear receptors as new regulators of testis immune privilege

    Principal investigator: dr Alicja Kinga Kamińska

    Uniwersytet Jagielloński

    Call: SONATA 20, Panel: NZ3

  29. 29. Structural studies based on low sequence similarity of G protein-coupled receptors activated by hormones and allosteric …

    Principal investigator: dr Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

    Call: SONATA 4, Panel: NZ1

  30. 30. Study of ligand binding and activation processes of formyl, opioid and cannabinoid G-protein-coupled receptors

    Principal investigator: prof. Sławomir Hubert Filipek

    Uniwersytet Warszawski, Wydział Chemii

    Call: OPUS 2, Panel: NZ1

  31. 31. Development of a comprehensive set of computational tools for the search of new ligands of particular receptor - case st…

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii PAN

    Call: OPUS 16, Panel: NZ2

  32. 32. Participation of transient receptor potential (TRP) channels premeable for calcium ions in memory formation and retrieva…

    Principal investigator: dr hab. Elżbieta Jolanta Salińska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 8, Panel: NZ4

  33. 33. Impact of selective modulators of estrogen and aryl hydrocarbon receptors on hypoxia/ischemia-induced neuronal cell dama…

    Principal investigator: Joanna Rzemieniec

    Instytut Farmakologii PAN

    Call: PRELUDIUM 1, Panel: NZ3

  34. 34. Development of a method for the structure prediction of GPCRs complexes with agonists and antagonists, including the lig…

    Principal investigator: dr Michał Koliński

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: SONATA 1, Panel: NZ2

  35. 35. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic …

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

    Call: OPUS 23, Panel: NZ7

  36. 36. Quinoxalino-2,3-diones as potent tools for exploration of ionotropic kainate receptors

    Principal investigator: dr hab. Ewa Monika Szymańska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 20, Panel: NZ7

  37. 37. Neurodevelopmental patomechanisms of triclocarban- and dichlorodiphenyldichloroetylene-induced effects: the role of apop…

    Principal investigator: dr hab. Małgorzata Kajta

    Instytut Farmakologii PAN

    Call: OPUS 10, Panel: NZ7

  38. 38. Coactivators and corepressors of progesterone receptors as a regulators of progesterone influence on the trissues in the…

    Principal investigator: dr Robert Jarosław Rękawiecki

    Instytut Rozrodu Zwierząt i Badań Żywności PAN

    Call: OPUS 9, Panel: NZ4

  39. 39. The mechanism of ligand binding and the conformational changes in the beta2-adrenergic receptor molecule

    Principal investigator: dr Anita Płazińska

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

    Call: SONATA 5, Panel: NZ2

  40. 40. Histamine H3/H4 receptors as the attractive target for the search of biologically active substances

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: MAESTRO 1, Panel: NZ4

  41. 41. Dual-acting 5-HT6/5-HT7 receptor antagonists: exploring beneficial effects for the treatment of neurodegenerative disord…

    Principal investigator: Michał Kamiński

    Uniwersytet Jagielloński

    Call: PRELUDIUM 24, Panel: NZ7

  42. 42. Mechanisms of Antidepressant Action of Psilocybin: The Role of 5-HT2B-5-HT1A Receptor Dimerization and GSK-3β Activation…

    Principal investigator: dr hab. Agata Faron-Górecka

    Instytut Farmakologii PAN

    Call: OPUS 27, Panel: NZ7

  43. 43. The role of mineralocorticoid receptor in the regulation of pituitary corticotroph cells secretory activity by glucocort…

    Principal investigator: dr hab. Mateusz Bujko

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

    Call: OPUS 27, Panel: NZ3

  44. 44. Yin and Yang effect of P2X and P1 purinergic receptors on compartment of hematopoietic stem cells

    Principal investigator: prof. Magdalena Józefa Kucia

    Warszawski Uniwersytet Medyczny

    Call: OPUS 23, Panel: NZ3

  45. 45. Dopaminergic modulation of high frequency oscillations in the rat olfactory bulb associated with the NMDA receptor hypof…

    Principal investigator: Jacek Wróbel

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: PRELUDIUM 20, Panel: NZ4

  46. 46. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search…

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  47. 47. Increasing the precision of chimeric antigen receptor (CAR)-mediated anticancer immunotherapy by using the chemokine-ind…

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny

    Call: OPUS 19, Panel: NZ6

  48. 48. Molecular mechanism underlying the anti-inflammatory action of CB2 receptor agonists in microglia: participation of the …

    Principal investigator: dr Natalia Eleonora Małek-Chudzik

    Politechnika Wrocławska

    Call: OPUS 19, Panel: NZ7

  49. 49. Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system…

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

    Call: SONATINA 4, Panel: NZ7

  50. 50. Investigation of molecular mechanisms of rapid antidepressant action of NLX-101, a biased agonist of the 5-HT1A receptor…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 18, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski